Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$12,929,856
+$5,007,877 QoQ
Shares Held
10,780
+25.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#1,121
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 28%
Shared 0%
None 72%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hodges Capital Management Inc. holds $30,757,198 across 7 Drug Manufacturers - General names. LLY ranks #1 (42.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
10,780 | $12,929,856 | |
| 2 | JNJ |
Johnson & Johnson
|
23,026 | $5,847,913 | |
| 3 | ABBV |
AbbVie Inc.
|
19,642 | $4,942,712 | |
| 4 | AMGN |
Amgen Inc
|
7,363 | $2,666,289 | |
| 5 | NVO |
Novo Nordisk A S
|
51,300 | $2,459,322 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
9,315 | $1,176,857 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,714 | $734,249 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,929,856 | 10,780 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $7,921,979 | 8,613 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $9,301,356 | 8,655 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $8,877,505 | 11,635 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $8,446,207 | 10,835 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $8,400,330 | 10,171 | Shares | Sole | 2025-06-02 | |
| 2024-12-31 | $8,434,872 | 10,926 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $5,916,307 | 6,678 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $6,888,131 | 7,608 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $5,624,650 | 7,230 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $4,841,150 | 8,305 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,077,890 | 7,592 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,077 | 0 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,852 | 11,158 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,797,212 | 7,646 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,162,241 | 6,687 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $1,661,354 | 5,124 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $4,108,836 | 14,348 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,876,747 | 14,035 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,771,444 | 11,995 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $1,348,889 | 5,877 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $1,346,224 | 7,206 | Shares | Sole | 2021-04-07 | |
| 2020-12-31 | $397,618 | 2,355 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $442,283 | 2,988 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $461,674 | 2,812 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $390,080 | 2,812 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||